News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
99,371 Results
Type
Article (3174)
Company Profile (27)
Press Release (96170)
Multimedia
Podcasts (8)
Webinars (2)
Section
Business (27368)
Career Advice (189)
Deals (9053)
Drug Delivery (1)
Drug Development (9875)
Employer Resources (5)
FDA (1903)
Job Trends (2260)
News (48379)
Policy (3452)
Tag
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
Academia (371)
Accelerated approval (5)
Adcomms (3)
Allergies (3)
Alliances (7640)
ALS (36)
Alzheimer's disease (490)
Antibody-drug conjugate (ADC) (36)
Approvals (1985)
Artificial intelligence (59)
Autoimmune disease (18)
Automation (6)
Bankruptcy (97)
Best Places to Work (2059)
Biosimilars (34)
Biotechnology (20)
Bladder cancer (10)
Brain cancer (18)
Breast cancer (57)
Cancer (582)
Cardiovascular disease (29)
Career advice (159)
Career pathing (3)
CAR-T (25)
CDC (2)
Celiac Disease (1)
Cell therapy (71)
Cervical cancer (6)
Clinical research (8650)
Collaboration (221)
Compensation (90)
Complete response letters (5)
COVID-19 (154)
CRISPR (2)
C-suite (142)
Cystic fibrosis (11)
Data (936)
Denatured (1)
Depression (73)
Diabetes (35)
Diagnostics (823)
Digital health (8)
Diversity, equity & inclusion (2)
Drug discovery (30)
Drug pricing (8)
Duchenne muscular dystrophy (19)
Earnings (9375)
Editorial (5)
Employer branding (2)
Employer resources (5)
Events (13919)
Executive appointments (208)
FDA (2341)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (2)
Funding (248)
Gene editing (8)
Gene therapy (38)
GLP-1 (64)
Government (273)
Guidances (75)
Healthcare (2623)
Huntington's disease (8)
IgA nephropathy (6)
Immunology and inflammation (29)
Immuno-oncology (10)
Indications (16)
Infectious disease (170)
Inflammatory bowel disease (38)
Inflation Reduction Act (1)
Influenza (9)
Intellectual property (49)
Interviews (35)
IPO (5206)
IRA (1)
Job creations (303)
Job search strategy (136)
JPM (15)
Layoffs (34)
Leadership (1)
Legal (999)
Liver cancer (5)
Longevity (3)
Lung cancer (75)
Lymphoma (35)
Machine learning (3)
Management (1)
Manufacturing (72)
MASH (14)
Medical device (2157)
Medtech (2164)
Mergers & acquisitions (4324)
Metabolic disorders (98)
Multiple sclerosis (44)
NASH (1)
Neurodegenerative disease (87)
Neuropsychiatric disorders (41)
Neuroscience (1041)
Neurotech (1)
NextGen: Class of 2026 (1125)
Non-profit (396)
Now hiring (3)
Obesity (48)
Opinion (14)
Ovarian cancer (23)
Pain (34)
Pancreatic cancer (59)
Parkinson's disease (113)
Partnered (3)
Patents (99)
Patient recruitment (58)
Peanut (2)
People (9639)
Pharmaceutical (2)
Pharmacy benefit managers (3)
Phase 1 (2502)
Phase 2 (3808)
Phase 3 (3060)
Pipeline (831)
Policy (9)
Postmarket research (277)
Preclinical (1140)
Press Release (1)
Prostate cancer (23)
Psychedelics (13)
Radiopharmaceuticals (55)
Rare diseases (89)
Real estate (679)
Recruiting (2)
Regulatory (2720)
Reports (6)
Research institute (377)
Resumes & cover letters (23)
Rett syndrome (5)
RNA editing (1)
RSV (7)
Schizophrenia (96)
Series A (39)
Series B (32)
Sickle cell disease (17)
Special edition (5)
Spinal muscular atrophy (36)
Sponsored (1)
Startups (630)
State (1)
Stomach cancer (1)
Supply chain (8)
Tariffs (3)
The Weekly (7)
Vaccines (51)
Venture capital (12)
Weight loss (12)
Women's health (6)
Date
Today (2)
Last 7 days (89)
Last 30 days (357)
Last 365 days (4899)
2026 (460)
2025 (4943)
2024 (5971)
2023 (7105)
2022 (8541)
2021 (9901)
2020 (9218)
2019 (6646)
2018 (5133)
2017 (4977)
2016 (4292)
2015 (5731)
2014 (3959)
2013 (3135)
2012 (3253)
2011 (2885)
2010 (2578)
Location
Africa (41)
Alabama (7)
Arizona (51)
Arkansas (2)
Asia (5293)
Australia (683)
California (1975)
Canada (389)
China (128)
Colorado (58)
Connecticut (98)
Delaware (35)
Europe (8996)
Florida (351)
Georgia (40)
Idaho (9)
Illinois (215)
India (2)
Indiana (109)
Japan (49)
Kansas (19)
Kentucky (8)
Louisiana (4)
Maine (49)
Maryland (240)
Massachusetts (1255)
Michigan (74)
Minnesota (92)
Mississippi (4)
Missouri (19)
Montana (4)
Nebraska (5)
Nevada (38)
New Hampshire (19)
New Jersey (530)
New Mexico (3)
New York (655)
North Carolina (308)
Northern California (773)
Ohio (51)
Oregon (3)
Pennsylvania (427)
Puerto Rico (1)
Rhode Island (6)
South America (91)
South Carolina (12)
Southern California (940)
Tennessee (49)
Texas (403)
United States (7206)
Utah (71)
Vermont (1)
Virginia (52)
Washington D.C. (6)
Washington State (117)
West Virginia (1)
Wisconsin (26)
99,371 Results for "dart neuroscience llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aligos Therapeutics Presents Positive Data at HEP-DART 2025
December 12, 2025
·
6 min read
Press Releases
Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)
January 5, 2026
·
5 min read
Press Releases
Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium
December 5, 2025
·
5 min read
Press Releases
Precision BioSciences Announces Presentation of Clinical Data from the ELIMINATE-B Trial at HEP-DART 2025
November 20, 2025
·
6 min read
Press Releases
Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study
January 7, 2026
·
7 min read
Press Releases
ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing
February 1, 2026
·
7 min read
Press Releases
Apollo Neuroscience Announces 2025 Year in Review
February 2, 2026
·
6 min read
Press Releases
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
December 29, 2025
·
1 min read
Press Releases
AlzeCure Pharma Selected to Present at the Bio-Neuroscience conference in Amsterdam
February 2, 2026
·
3 min read
Press Releases
Klotho Neurosciences to Present at the Biotech Showcase 2026
January 8, 2026
·
2 min read
1 of 9,938
Next
